Study ID: TV48125-CNS-20024
Study Title
- A Study to Test if Fremanezumab Reduces Headache in Patients With Posttraumatic Headache (PTH)
Teva Identifier
- TV48125-CNS-20024
ClinicalTrials.gov Identifier
- NCT03347188
Study Status
- Completed
Trial Condition(s)
- Post-Traumatic Headache
Interventions
- Drug: Fremanezumab | Drug: Placebo
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
Gender
- Female, Male
Age Range
- 18 Years to 70 Years
Trial Duration
- November 17, 2017 - June 3, 2020
Phase
- Phase 2
Study Type
Interventional
